Amic AB Product Pipeline Analysis

SUMMARY

Amic AB Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Amic AB's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List Of Tables 5
1.2 List of Figures 6
2 Company Overview 7
2.1 Key Information 7
2.2 Industry Outlook -- In Vitro Diagnostics 7
3 Major Products and Services 8
3.1 Overview 8
4 Competitors 9
5 Key Employees 10
6 Locations And Subsidiaries 11
6.1 Head Office 11
7 Recent Developments 12
7.1 Product News 12
7.1.1 Jan 03, 2008: Åmic Signs Non-Exclusive License Agreement With Roche Diagnostics For Key Cardiac Marker NT-proBNP 12
8 Amic AB Pipeline Products 13
8.1 Amic AB Product Pipeline Analysis 13
8.1.1 Amic AB Pipeline Products By Equipment Type 13
8.1.2 Amic AB Pipeline Products By Development Stage 14
8.1.3 Amic AB Pipeline Products By Therapy Area 15
8.1.4 Amic AB Pipeline Products By News Summary 15
8.2 NT-proBNP 15
8.2.1 Product Description 15
8.2.2 Product Status 15
8.3 Forecast POC Diagnostic System 16
8.3.1 Product Description 16
8.3.2 Product Status 16
8.3.3 Product Milestone 16
8.4 Optical fluorescence reader 17
8.4.1 Product Description 17
8.4.2 Product Status 17
9 Appendix 18
9.1 Methodology 18
9.1.1 Coverage 18
9.1.2 Secondary Research 19
9.1.3 Primary Research 19
9.1.4 Expert Panel Validation 20
9.2 Contact Us 20
9.3 About Global Markets Direct 20
9.4 Disclaimer 20

1.1 List of Tables
Table 1: Amic AB,Key Facts 7
Table 2: Amic AB, Key Employees, 10
Table 3: Amic AB Pipeline Products by Equipment Type 13
Table 4: Amic AB Pipeline Products By Development Stage 14
Table 5: Amic AB Pipeline Products By Therapy Area 15
Table 6: Amic AB Pipeline Products By News Summaries 15

1.2 List of Figures
Figure 1: Amic AB Pipeline Products By Development Stage 14
Figure 2: Global Markets Direct Methodology 18